Obesity predicts persistence of pain in children with functional gastrointestinal disorders

S Bonilla1, D Wang, M Saps

  • 1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Memorial Hospital, Northwestern University, Chicago, IL 60614, USA.

Insights

Obesity in children with functional gastrointestinal disorders (FGIDs) is linked to persistent abdominal pain and greater disability. These findings highlight obesity as a key factor impacting FGID outcomes in pediatric patients.

Area of Science:

  • Pediatric Gastroenterology
  • Childhood Obesity Research
  • Functional Gastrointestinal Disorders (FGIDs)

Background:

  • Functional gastrointestinal disorders (FGIDs) are common in children, often presenting with abdominal pain.
  • The impact of obesity on the long-term prognosis of pediatric FGIDs remains understudied.
  • Obesity may influence the severity and persistence of symptoms in children with FGIDs.

Purpose of the Study:

  • To investigate the association between obesity and the long-term outcome of children diagnosed with abdominal pain-related FGIDs.
  • To test the hypothesis that obesity is linked to a poorer prognosis in pediatric FGIDs.

Main Methods:

  • A prospective cohort study was conducted in an outpatient pediatric clinic.
  • Patients diagnosed with abdominal pain-related FGIDs were followed for 12-15 months.
  • Key outcomes included pain persistence, frequency, intensity, school absenteeism, and disruption of daily activities, compared between obese and non-obese children.

Main Results:

  • Overall, 20.2% of the pediatric FGID patients were obese.
  • Obese children were significantly more likely to experience persistent abdominal pain (P<0.0001), higher pain intensity (P=0.0002), and increased frequency of pain (P=0.0032) at follow-up.
  • Obesity was also strongly associated with greater school absenteeism (P<0.0001) and disruption of daily activities (P<0.0001) in this cohort.

Conclusions:

  • Obesity is significantly associated with poor long-term outcomes and increased disability in children suffering from abdominal pain-related FGIDs.
  • These findings underscore the importance of considering obesity in the management and prognostic assessment of pediatric FGIDs.
  • The study highlights novel insights with potential implications for clinical practice and treatment strategies for FGIDs in children.
Abstract

Related Concept Videos

Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...